INST 0817: Compassionate Use of Mifepristone.

Trial Profile

INST 0817: Compassionate Use of Mifepristone.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 04 Aug 2016

At a glance

  • Drugs Mifepristone (Primary)
  • Indications Adrenocortical carcinoma; Breast cancer; Central serous chorioretinopathy; Colon cancer; Cushing syndrome; Endometrial cancer; Meningioma; Ovarian cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Aug 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 18 Dec 2012 Primary endpoint amended as reported by ClinicalTrials.gov.
    • 22 Oct 2012 Planned end date changed from 1 Nov 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top